JPS6031831B2 - ７−置換−８−アミノメチル−イソフラボン誘導体の製造方法 - Google Patents

７−置換−８−アミノメチル−イソフラボン誘導体の製造方法

Info

Publication number
JPS6031831B2
JPS6031831B2 JP50052599A JP5259975A JPS6031831B2 JP S6031831 B2 JPS6031831 B2 JP S6031831B2 JP 50052599 A JP50052599 A JP 50052599A JP 5259975 A JP5259975 A JP 5259975A JP S6031831 B2 JPS6031831 B2 JP S6031831B2
Authority
JP
Japan
Prior art keywords
isoflavone
general formula
group
isopropoxy
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP50052599A
Other languages
English (en)
Japanese (ja)
Other versions
JPS51125082A (en
Inventor
フオイア− ラスツロ
ドリイ イストバン
フアルカス ロ−ランド
イグラデイ ミハリイ
ポルガル ネ− ナギイ マリア
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KINOIN GIOGISUZERU ESU BEGIESUZECHI TERUKEMEKU GIARARUTO
Original Assignee
KINOIN GIOGISUZERU ESU BEGIESUZECHI TERUKEMEKU GIARARUTO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by KINOIN GIOGISUZERU ESU BEGIESUZECHI TERUKEMEKU GIARARUTO filed Critical KINOIN GIOGISUZERU ESU BEGIESUZECHI TERUKEMEKU GIARARUTO
Publication of JPS51125082A publication Critical patent/JPS51125082A/ja
Publication of JPS6031831B2 publication Critical patent/JPS6031831B2/ja
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/34—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only
    • C07D311/36—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only not hydrogenated in the hetero ring, e.g. isoflavones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP50052599A 1974-05-03 1975-05-02 ７−置換−８−アミノメチル−イソフラボン誘導体の製造方法 Expired JPS6031831B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU1474/75 1974-05-03
HUCI1474A HU168753B (pl) 1974-05-03 1974-05-03

Publications (2)

Publication Number Publication Date
JPS51125082A JPS51125082A (en) 1976-11-01
JPS6031831B2 true JPS6031831B2 (ja) 1985-07-24

Family

ID=10994519

Family Applications (1)

Application Number Title Priority Date Filing Date
JP50052599A Expired JPS6031831B2 (ja) 1974-05-03 1975-05-02 ７−置換−８−アミノメチル−イソフラボン誘導体の製造方法

Country Status (18)

Country Link
JP (1) JPS6031831B2 (pl)
AR (1) AR205818A1 (pl)
AT (1) AT344167B (pl)
CH (1) CH611289A5 (pl)
CS (1) CS183794B2 (pl)
DD (1) DD119587A1 (pl)
DE (1) DE2518986A1 (pl)
DK (1) DK191375A (pl)
FI (1) FI63568C (pl)
FR (1) FR2269340B1 (pl)
GB (1) GB1482238A (pl)
HU (1) HU168753B (pl)
IL (1) IL47196A (pl)
NL (1) NL7505214A (pl)
NO (2) NO147485C (pl)
PL (1) PL99666B1 (pl)
SU (1) SU576938A3 (pl)
YU (1) YU37335B (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2516921A1 (fr) * 1981-11-25 1983-05-27 Lipha Haloalkyl-8-4h-(1) benzopyran-4-ones, et procedes de preparation
USRE40792E1 (en) 1992-05-19 2009-06-23 Novogen Research Pty Ltd Health supplements containing phyto-oestrogens, analogues or metabolites thereof
AUPO203996A0 (en) 1996-08-30 1996-09-26 Novogen Research Pty Ltd Therapeutic uses
US6146668A (en) 1997-04-28 2000-11-14 Novogen, Inc. Preparation of isoflavones from legumes
AUPP260798A0 (en) 1998-03-26 1998-04-23 Novogen Research Pty Ltd Treatment of medical related conditions with isoflavone containing extracts of clover
AUPQ266199A0 (en) 1999-09-06 1999-09-30 Novogen Research Pty Ltd Compositions and therapeutic methods involving isoflavones and analogues thereof
AUPR363301A0 (en) 2001-03-08 2001-04-05 Novogen Research Pty Ltd Dimeric isoflavones
CN101429186B (zh) * 2007-11-08 2012-11-21 中国医学科学院药物研究所 松属素外消旋体的拆分方法

Also Published As

Publication number Publication date
DE2518986A1 (de) 1975-11-20
DK191375A (da) 1975-11-04
YU111775A (en) 1983-04-27
FR2269340B1 (pl) 1980-01-25
PL99666B1 (pl) 1978-07-31
CH611289A5 (en) 1979-05-31
NO147485B (no) 1983-01-10
IL47196A0 (en) 1975-06-25
JPS51125082A (en) 1976-11-01
FI63568B (fi) 1983-03-31
FI63568C (fi) 1983-07-11
IL47196A (en) 1978-07-31
NO151177C (no) 1985-02-27
YU37335B (en) 1984-08-31
CS183794B2 (en) 1978-07-31
AR205818A1 (es) 1976-06-07
NO151177B (no) 1984-11-19
NL7505214A (nl) 1975-11-05
NO147485C (no) 1983-04-20
ATA332075A (de) 1977-11-15
DD119587A1 (pl) 1976-05-05
FI751272A (pl) 1975-11-04
AT344167B (de) 1978-07-10
HU168753B (pl) 1976-07-28
SU576938A3 (ru) 1977-10-15
NO810931L (no) 1975-11-04
AU8072375A (en) 1976-11-04
FR2269340A1 (pl) 1975-11-28
NO751567L (pl) 1975-11-04
GB1482238A (en) 1977-08-10

Similar Documents

Publication Publication Date Title
US3949085A (en) Anabolic-weight-gain promoting compositions containing isoflavone derivatives and method using same
CN85101722A (zh) 制备二氢哒嗪酮衍生物的方法
US4213994A (en) Imidazolyl-(2)-carbinols having hypolipidemic action and process for preparing them
PL90015B1 (pl)
JPH0261477B2 (pl)
US3864362A (en) Iso flavones
JPS58174319A (ja) 薬剤組成物
JPS593998B2 (ja) ７−イソプロピルオキシイソフラボンの製造方法
JPS6152147B2 (pl)
JPS6031831B2 (ja) ７−置換−８−アミノメチル−イソフラボン誘導体の製造方法
US3715375A (en) New diphenyl sulfones
US3907830A (en) Isoflavone derivatives
US3674873A (en) Method of treating or preventing coccidiosis
JPS58174313A (ja) 動物組織の線維化抑制剤
US3666860A (en) Substituted nitroimidazolylthiadiazoles and oxadiazoles as antiprotozoal agents
GB2081708A (en) Novel derivatives of (1-benzyl-1h-indazol-3-yl) oxyacetic acid and pharmaceutical composition containing it
JPH0339513B2 (pl)
US3143469A (en) Anti-cholesterol nicotinic acid nu-oxide
JPS5962584A (ja) コクシジユ−ム症に対して活性なキナゾリノン誘導体
EP0260400A2 (en) Method of treating diabetes with 5-[1-hydroxy-2-(isopropylamino)-ethyl]anthranilonitrile
US3773943A (en) Alpha,alpha,alpha-trifluoro-6-substituted-5-nitro-m-toluic acid,5'-nitrofurylidene hydrazide compounds as growth promotants
US11905282B1 (en) 1-cyclopropyl-7-(4-((5-(2,4-dichlorobenzylideneamino)-2-thioxo-1,3,4-thiadiazol-3(2H)-yl)methyl)piperazin-1-yl)-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid as an anti-inflammatory compound
US11958848B1 (en) 7-(4-((5-(2-chlorobenzylideneamino)-2-thioxo-1,3,4-thiadiazol-3(2H)-yl)methyl)piperazin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid as an anti-inflammatory compound
US11891385B1 (en) 1-cyclopropyl-7-(4-((5-(3,5-dichlorobenzylideneamino)-2-thioxo-1,3,4-thiadiazol-3(2H)-yl)methyl)piperazin-1-yl)-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic aci d as an anti-inflammatory compound
US11884651B1 (en) 7-(4-((4-benzylidene-5-oxo-2-phenyl-4,5-dihydro-1H-imidazol-1-yl)methyl)piperazin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid as an anti-inflammatory compound